Sysmex Corporation (TYO: 6869)

Market Cap	1.83T
Revenue (ttm)	491.29B
Net Income (ttm)	53.46B
Shares Out	623.57M
EPS (ttm)	85.65
PE Ratio	34.20
Forward PE	29.07
Dividend	30.00 (1.03%)
Ex-Dividend Date	Mar 28, 2025

Volume	916,300
Average Volume	1,229,655
Open	2,915.50
Previous Close	2,903.50
Day's Range	2,909.50 - 2,947.50
52-Week Range	2,138.00 - 3,236.00
Beta	0.65
RSI	47.62
Earnings Date	Feb 12, 2025

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers;...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1968
• Employees: 10,042
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6869

Financial Performance

In 2023, Sysmex's revenue was 461.51 billion, an increase of 12.43% compared to the previous year's 410.50 billion. Earnings were 49.64 billion, an increase of 8.42%.